Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial

BACKGROUND: In a randomized trial, Lianhuaqingwen (LHQW) capsule was effective for accelerating symptom recovery among patients with coronavirus disease 2019 (COVID-19). However, the lack of blinding and limited sample sizes decreased the level of clinical evidence. OBJECTIVES: To evaluate the effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jin-ping, Ling, Yun, Jiang, Liang-shuang, Mootsikapun, Piroon, Lu, Hong-zhou, Chayakulkeeree, Methee, Zhang, Li-xiu, Arttawejkul, Pureepat, Hu, Feng-yu, Truong, Thi Ngoc Lan, Perez, Roxan A., Gu, Xing, Sun, Hui-min, Jiang, Jian-jie, Liu, Ren-jie, Ding, Zhen, Zhan, Yang-qing, Yang, Zi-feng, Guan, Wei-jie, Zhong, Nan-shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685492/
https://www.ncbi.nlm.nih.gov/pubmed/38017515
http://dx.doi.org/10.1186/s12985-023-02144-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685492/
https://www.ncbi.nlm.nih.gov/pubmed/38017515
http://dx.doi.org/10.1186/s12985-023-02144-6

Ejemplares similares